Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 24, 2021
0
Date of Patent
December 12, 2023
0
Patent Application Number
17357444
0
Patent Citations
‌
US Patent 7408047 Fibroblast growth factor-like polypeptides
0
‌
US Patent 7696153 G-CSF conjugates
0
‌
US Patent 7696172 Fibroblast growth factor-like polypeptides
0
‌
US Patent 7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
0
‌
US Patent 7704952 Methods for treating diabetes using fibroblast growth factor-like polypeptides
0
‌
US Patent 7727742 Nucleic acid molecules encoding fibroblast growth factor-like polypeptides
0
‌
US Patent 7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
0
‌
US Patent 7879323 Antibodies to fibroblast growth factor-like polypeptides
0
‌
US Patent 7887799 Antibodies to fibroblast growth factor-like polypeptides
0
‌
US Patent 8361963 Uses of FGF21 polypeptides comprising two or more mutations
0
•••
Patent Inventor Names
Agnes Eva Hamburger
0
Jeonghoon Sun
0
Jing Xu
0
Randy Ira Hecht
0
Edward John Belouski
0
Yue-Sheng Li
0
Mark Leo Michaels
0
Murielle Marie Ellison
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11840558
0
Patent Primary Examiner
‌
Christine J. Saoud
0

Find more entities like US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo